MedTrace Logo

Comparative Study of Three Different Testing Mechanisms for Clostridium Difficile

NCT01066221 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 470

Last updated 2011-07-20

No results posted yet for this study

Summary

The purpose of this study is to establish which of the following tests perform best in diagnosing clostridium difficile. PCR, Enzyme Immunoassays (EIA) and C. difficile cytotoxin assay (CTA).

Conditions

  • Clostridium Difficile

Sponsors & Collaborators

  • McMaster University

    collaborator OTHER

  • St. Joseph's Healthcare Hamilton

    collaborator OTHER

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Christine Lee, MD · St. Joseph's Health Care London

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-03-31
Completion
2010-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01066221 on ClinicalTrials.gov